Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans

NeuroImage
A H KempP J Nathan

Abstract

The serotonergic system is one of the major systems targeted in the pharmacological treatment of a wide range of mood disorders including depression; however, little is known about the neurophysiological mechanisms underlying the effects of serotonin (5-HT) on affective phenomena including emotional behaviours, mood and emotional processing. The aim of the current study was to investigate how 5-HT acutely modulates steady-state visually evoked potentials (SSVEP), heart rate (HR) and verbal ratings associated with the viewing of differently valent emotional images. In a randomised double-blind, placebo-controlled design, 17 healthy subjects were tested under two acute treatment conditions: placebo and citalopram (20 mg) (a selective serotonin re-uptake inhibitor, or SSRI). Participants were tested 2 h post treatment whilst viewing 75 images (categorised as pleasant, neutral or unpleasant). Results indicate that under placebo treatment, processing of unpleasant valence [unpleasant (-) neutral images] was associated with decreases in SSVEP amplitude and latency in frontal and occipital cortices, whereas processing of pleasant valence [pleasant (-) neutral images] was associated with amplitude decreases and latency increases within...Continue Reading

Associated Clinical Trials

References

Jan 1, 1986·Annals of the New York Academy of Sciences·R A Depue, M R Spoont
Jan 1, 1994·Electroencephalography and Clinical Neurophysiology·P L NunezR Srinivasan
Jan 1, 1995·Electroencephalography and Clinical Neurophysiology·R B SilbersteinA Pipingas
Feb 1, 1995·Journal of Clinical Psychopharmacology·C SalzmanE Miyawaki
Nov 1, 1994·Archives of General Psychiatry·M S NoblerD P Devanand
Nov 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M A EllenbogenC Benkelfat
Jul 1, 1997·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·D PalombaA Mini
Jan 1, 1997·Journal of Psychopharmacology·J G ReillyA H Young
Mar 21, 1998·The American Journal of Psychiatry·B KnutsonV I Reus
Aug 27, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S B ManuckM F Muldoon
Dec 23, 1998·Archives of General Psychiatry·R B SilbersteinF C Jarman
Mar 13, 1999·Annual Review of Psychology·J T Cacioppo, W L Gardner
May 11, 1999·Trends in Cognitive Sciences·R J Davidson, W Irwin
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Dec 1, 1999·Biological Psychology·M Hansenne, M Ansseau
May 10, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·R B SilbersteinP Harris
Nov 7, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·P MooreJ C Gillin
Feb 13, 2001·Journal of Affective Disorders·J F Thayer, R D Lane
Apr 11, 2001·Seminars in Clinical Neuropsychiatry·A L BrodyS Saxena
Apr 21, 2001·Journal of Affective Disorders·A J Van der Does
Jun 27, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D S MoskowitzS N Young
Oct 6, 2001·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·R B SilbersteinF Danieli
May 3, 2002·The American Journal of Psychiatry·Helen S MaybergPaul A Jerabek

❮ Previous
Next ❯

Citations

Sep 25, 2007·Psychopharmacology·Ingmar H A FrankenLolke Pepplinkhuizen
Jan 29, 2014·Brain Research·Kai MacDonald, David Feifel
Nov 18, 2011·Psychological Medicine·O J RobinsonC Grillon
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christian GrillonDaniel S Pine
May 23, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M C WichersJ van Os
Sep 15, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christian GrillonDaniel S Pine
Jun 15, 2007·Schizophrenia Bulletin·Mary L Phillips, Eduard Vieta
Jun 15, 2006·Clinical Neuropharmacology·Montserrat SerraOlivier Blin
May 23, 2009·Journal of Psychopharmacology·J R Cardoso de AlmeidaG F Busatto
Oct 18, 2005·Alimentary Pharmacology & Therapeutics·T O C KilkensR-J M Brummer
Jun 9, 2012·IEEE Pulse·Richard B Silberstein, Geoffrey E Nield
Jul 6, 2011·The International Journal of Neuropsychopharmacology·Mei-See ManAngela C Roberts
Oct 15, 2011·The International Journal of Neuropsychopharmacology·Izelle LabuschagnePradeep J Nathan
Dec 2, 2015·IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society·Hao-Teng HsuPo-Lei Lee
May 26, 2017·Depression and Anxiety·Raoul DieterichNorbert Kathmann
May 24, 2018·European Archives of Psychiatry and Clinical Neuroscience·Ali KhaleghiMohammad Reza Mohammadi
May 9, 2009·Brain and Cognition·Mattie TopsDon M Tucker
Jul 5, 2011·Journal of Affective Disorders·Julian G Simmons, Nicholas B Allen
Jun 18, 2021·Neuroscience and Biobehavioral Reviews·Marina BaroniGrazia Rutigliano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.